• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎患者中低调节性CD25高表达+CD4+和高促炎性CD28阴性+CD4+ T细胞亚群的表现:经选择性粒细胞和单核细胞吸附性血液成分分离术改善。

Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.

作者信息

Yokoyama Yoko, Fukunaga Ken, Fukuda Yoshihiro, Tozawa Katsuyuki, Kamikozuru Koji, Ohnishi Kunio, Kusaka Takeshi, Kosaka Tadashi, Hida Nobuyuki, Ohda Yoshio, Miwa Hiroto, Matsumoto Takayuki

机构信息

Division of Lower Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

出版信息

Dig Dis Sci. 2007 Oct;52(10):2725-31. doi: 10.1007/s10620-006-9560-z. Epub 2007 Apr 3.

DOI:10.1007/s10620-006-9560-z
PMID:17404876
Abstract

Low-CD25(High+)CD4(+), a subset of regulatory CD25(+)CD4(+) T cells and high-inflammatory CD28(-)CD4(+) T cells can exacerbate ulcerative colitis (UC). This study sought to investigate the frequency of CD25(High+)CD4(+) and CD28(-)CD4(+) T cells in patients with UC and the changes in these cells during Adacolumn granulocyte and monocyte adsorption apheresis (GMA). Subjects were 12 patients with active UC, 11 with quiescent UC, and 14 healthy volunteers (HVs). The mean clinical activity index was 15.7 +/- 2.2 in active UC and 4.5 +/- 1.1 in quiescent UC. Peripheral blood samples were stained with CD4, CD25, and CD28 antibodies for flow cytometry. Patients with active UC received GMA and blood samples were examined before and after the first GMA session. Patients with active UC (P < 0.04) or quiescent UC (P < 0.02) had a higher percentage of CD28(-)D4(+)T cells compared with HVs, while the percentage of CD28(+)CD4(+) T cells was lower in both UC groups compared with HVs (P = 0.03 and P < 0.02). Patients with active UC had a lower percentage of CD25(High+)CD4(+)T cells compared with quiescent UC patients (P < 0.001). A significant increase in CD25(High+)CD4(+) T cells was associated with GMA (P < 0.03). Low CD25(High+)CD4(+) and high CD28(-)CD4(+) are prominent features in UC. The increase in CD25(High+)CD4(+) T cells induced by GMA should contribute to improved immune function. Additional studies are warranted, since a low frequency of CD25(High+)CD4(+) (-) and a high frequency of CD28(-)CD4(+) (-) expressing T cells might be a predictor of clinical response to GMA.

摘要

低CD25(高+)CD4(+),即调节性CD25(+)CD4(+)T细胞的一个亚群以及高炎症性CD28(-)CD4(+)T细胞,可加重溃疡性结肠炎(UC)。本研究旨在调查UC患者中CD25(高+)CD4(+)和CD28(-)CD4(+)T细胞的频率以及在阿达柱粒细胞和单核细胞吸附去除术(GMA)过程中这些细胞的变化。研究对象为12例活动期UC患者、11例静止期UC患者和14名健康志愿者(HV)。活动期UC患者的平均临床活动指数为15.7±2.2,静止期UC患者为4.5±1.1。外周血样本用CD4、CD25和CD28抗体染色以进行流式细胞术检测。活动期UC患者接受GMA治疗,并在首次GMA治疗前后检查血样。活动期UC患者(P<0.04)或静止期UC患者(P<0.02)的CD28(-)D4(+)T细胞百分比相较于HV更高,而两个UC组的CD28(+)CD4(+)T细胞百分比相较于HV更低(P=0.03和P<0.02)。活动期UC患者的CD25(高+)CD4(+)T细胞百分比相较于静止期UC患者更低(P<0.001)。CD25(高+)CD4(+)T细胞的显著增加与GMA相关(P<0.03)。低CD25(高+)CD4(+)和高CD28(-)CD4(+)是UC的突出特征。GMA诱导的CD25(高+)CD4(+)T细胞增加应有助于改善免疫功能。鉴于低频率的CD25(高+)CD4(+)(-)和高频率的CD28(-)CD4(+)(-)表达T细胞可能是对GMA临床反应的一个预测指标,因此有必要进行更多研究。

相似文献

1
Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.溃疡性结肠炎患者中低调节性CD25高表达+CD4+和高促炎性CD28阴性+CD4+ T细胞亚群的表现:经选择性粒细胞和单核细胞吸附性血液成分分离术改善。
Dig Dis Sci. 2007 Oct;52(10):2725-31. doi: 10.1007/s10620-006-9560-z. Epub 2007 Apr 3.
2
The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.活动期和静止期溃疡性结肠炎患者中功能性调节性T细胞(CD4+CD25high+/叉头框蛋白P3+)的表达谱
Clin Exp Immunol. 2009 May;156(2):320-7. doi: 10.1111/j.1365-2249.2009.03904.x. Epub 2009 Mar 9.
3
The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy.在活动期和缓解期以及结肠切除术后的溃疡性结肠炎患者中,CD4+CD28null 和调节性 CD4+CD25High T 细胞表型。
Cytokine. 2011 Nov;56(2):466-70. doi: 10.1016/j.cyto.2011.06.021. Epub 2011 Jul 28.
4
Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy.从溃疡性结肠炎患者的白细胞分离产物中制备功能保存的CD4+ CD25高调节性T细胞,适用于调节性T细胞转移疗法。
Cytotherapy. 2008;10(7):698-710. doi: 10.1080/14653240802345812.
5
Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.未经治疗的溃疡性结肠炎患者中,具有受损抑制功能的CD4(+) CD25(+) CD127(低) FoxP3(+)调节性T细胞减少。
Autoimmunity. 2015;48(8):556-61. doi: 10.3109/08916934.2015.1070835. Epub 2015 Aug 31.
6
Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.粒细胞和单核细胞吸附去除术治疗儿童炎症性肠病的安全性和有效性:一项前瞻性试点研究。
J Pediatr Gastroenterol Nutr. 2008 Apr;46(4):386-91. doi: 10.1097/MPG.0b013e31815604e5.
7
Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.在溃疡性结肠炎患者进行选择性粒细胞和单核细胞单采术期间,临床反应与血浆白细胞介素-1受体拮抗剂升高有关。
Dig Dis Sci. 2006 Sep;51(9):1525-31. doi: 10.1007/s10620-005-9012-1. Epub 2006 Aug 12.
8
In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.在溃疡性结肠炎患者中,粒细胞和单核细胞的吸附性消耗会影响中性粒细胞的黏膜水平,并且在初治患者中临床效果最为显著。
Dig Liver Dis. 2008 Sep;40(9):731-6. doi: 10.1016/j.dld.2008.02.012. Epub 2008 Apr 2.
9
Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.剂量强化粒细胞-单核细胞单采术治疗难治性溃疡性结肠炎
Artif Organs. 2015 Feb;39(2):187-92. doi: 10.1111/aor.12329. Epub 2014 Jul 1.
10
Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.巨细胞病毒阳性溃疡性结肠炎患者行粒细胞-单核细胞吸附疗法与免疫抑制剂治疗的效果及安全性比较。
Digestion. 2011;84(1):3-9. doi: 10.1159/000321911. Epub 2011 Feb 9.

引用本文的文献

1
Helicobacter Pylori infection in children with inflammatory bowel disease: a prospective multicenter study.儿童炎症性肠病中幽门螺杆菌感染:一项前瞻性多中心研究。
BMC Pediatr. 2024 Jun 29;24(1):417. doi: 10.1186/s12887-024-04902-z.
2
Efficacy and Safety of Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction for Intractable Ulcerative Colitis.乌帕替尼联合强化粒细胞和单核细胞吸附性治疗作为难治性溃疡性结肠炎诱导治疗的疗效和安全性
J Clin Med Res. 2024 May;16(5):256-263. doi: 10.14740/jocmr5165. Epub 2024 May 29.
3
Therapeutic Granulomonocytapheresis as a Non-pharmacologic Treatment Option for Inflammatory Bowel Disease: Efficacy Reports on a Wide Age Range and Disease Profile.

本文引用的文献

1
A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis.一项对溃疡性结肠炎患者选择性粒细胞和单核细胞单采临床反应预测因素的回顾性研究。
Dig Dis Sci. 2006 Nov;51(11):2031-8. doi: 10.1007/s10620-006-9199-9. Epub 2006 Sep 27.
2
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.炎症性肠病:流行病学、发病机制及治疗机遇
Inflamm Bowel Dis. 2006 Jan;12 Suppl 1:S3-9. doi: 10.1097/01.mib.0000195385.19268.68.
3
State of the art: IBD therapy and clinical trials in IBD.
治疗性粒细胞单采术作为炎症性肠病的一种非药物治疗选择:关于广泛年龄范围和疾病谱的疗效报告
Cureus. 2023 Nov 16;15(11):e48913. doi: 10.7759/cureus.48913. eCollection 2023 Nov.
4
Use of granulocyte and monocyte adsorption apheresis in dermatology (Review).粒细胞和单核细胞吸附性血液成分单采术在皮肤病学中的应用(综述)
Exp Ther Med. 2022 Jun 24;24(2):536. doi: 10.3892/etm.2022.11463. eCollection 2022 Aug.
5
Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective.粒细胞/单核细胞分离术在溃疡性结肠炎中的应用:从欧洲角度的实用综述。
World J Gastroenterol. 2021 Mar 14;27(10):908-918. doi: 10.3748/wjg.v27.i10.908.
6
Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies.介导的针对胃外免疫和炎症性疾病的保护作用:证据与争议
Diseases. 2015 Mar 27;3(2):34-55. doi: 10.3390/diseases3020034.
7
Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative Colitis.黄芩汤及其成分对溃疡性结肠炎发病机制的调控作用
Evid Based Complement Alternat Med. 2017;2017:7016468. doi: 10.1155/2017/7016468. Epub 2017 Jun 12.
8
Disrupted regulatory T cell homeostasis in inflammatory bowel diseases.炎症性肠病中调节性T细胞稳态的破坏
World J Gastroenterol. 2016 Jan 21;22(3):974-95. doi: 10.3748/wjg.v22.i3.974.
9
An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease.一项关于在活动期克罗恩病中强化与每周进行粒细胞和单核细胞单采术对比的开放标签前瞻性随机多中心研究。
BMC Gastroenterol. 2015 Nov 19;15:163. doi: 10.1186/s12876-015-0390-3.
10
Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.通过吸附性白细胞去除术治疗炎症性肠病:一种不用药物进行治疗的愿望。
World J Gastroenterol. 2014 Aug 7;20(29):9699-715. doi: 10.3748/wjg.v20.i29.9699.
前沿进展:炎症性肠病治疗与炎症性肠病临床试验
Inflamm Bowel Dis. 2005 Nov;11 Suppl 1:S3-12. doi: 10.1097/01.mib.0000184852.84558.b2.
4
Clinical application of human CD4+ CD25+ regulatory T cells for the treatment of inflammatory bowel diseases.人CD4+CD25+调节性T细胞在炎症性肠病治疗中的临床应用。
Expert Opin Biol Ther. 2005 Apr;5(4):451-62. doi: 10.1517/14712598.5.4.451.
5
Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?用于选择性白细胞去除术的阿达柱作为免疫系统疾病患者的非药物治疗方法:药物治疗的辅助手段还是替代方法?
J Clin Apher. 2005 Oct;20(3):171-84. doi: 10.1002/jca.20046.
6
Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.粒细胞/单核细胞吸附性血液成分去除术对活动期溃疡性结肠炎炎症细胞因子分泌的抑制作用
Ther Apher Dial. 2005 Apr;9(2):123-7. doi: 10.1111/j.1774-9987.2005.00229.x.
7
Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.粒细胞/单核细胞单采术治疗活动期溃疡性结肠炎的临床评估
Dig Liver Dis. 2004 Dec;36(12):811-7. doi: 10.1016/j.dld.2004.08.004.
8
Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.粒细胞单采术治疗类固醇依赖型炎症性肠病:一项前瞻性、开放性、试点研究。
Aliment Pharmacol Ther. 2004 Dec;20(11-12):1347-52. doi: 10.1111/j.1365-2036.2004.02288.x.
9
Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.粒细胞和单核细胞吸附性血液成分去除术治疗活动性远端溃疡性结肠炎:一项前瞻性试点研究。
Aliment Pharmacol Ther. 2004 Oct 1;20(7):783-92. doi: 10.1111/j.1365-2036.2004.02189.x.
10
CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.人肠道固有层中的CD4+CD25bright T细胞作为调节性细胞。
J Immunol. 2004 Sep 1;173(5):3119-30. doi: 10.4049/jimmunol.173.5.3119.